Notable Downgrades: La Quinta Holdings (LQ), Lexicon Pharmaceuticals. (LXRX), Barrick Gold (ABX), Intuit (INTU)

Analysts at Citigroup (C) downgraded La Quinta Holdings Inc. (LQ) from ‘Buy’ to ‘Neutral’ in a research report issued to clients on Friday. The name was also downgraded to ‘Neutral’ from ‘Overweight’ at JP Morgan (JPM).

On valuation measures, La Quinta Holdings Inc. stock it’s trading at a forward P/E multiple of 20.43x, and at a multiple of 204.56x this year’s estimated earnings. The t-12-month revenue at La Quinta Holdings is $998.91 million. LQ ‘s ROE for the same period is 1.32%.

Shares of the $2.11 billion market cap company are down 2.82% year-over-year and 14.01% year-to-date.

La Quinta Holdings Inc., currently with a median Wall Street price target of $26.00 and a high target of $28.00, dropped $2.81 to $16.16 in recent trading.

Lexicon Pharmaceuticals, Inc. (LXRX) was downgraded from ‘Hold’ to ‘Sell’ at Gabelli & Co. Shares have traded today between $13.90 and $15.25 with the price of the stock fluctuating between $5.60 to $15.79 over the last 52 weeks.

Lexicon Pharmaceuticals Inc. shares have a t-12 price/sales ratio of 67.76. EPS for the same period registers at ($1.09).

Shares of LXRX have lost $1.59 to $14.15 in mid-day trading on Friday, giving it a market cap of roughly $1.47 billion. The stock traded as high as $15.79 in Sept. 17, 2015.

RBC Capital Markets reported on Friday that they have lowered their Barrick Gold Corporation (ABX) target to $8 from $10 noting lower copper price forecasts and other model revisions reduce company’s net asset value by 25% and target.

Barrick Gold Corp. recently traded at $6.85, a gain of $0.01 over Thursday’s closing price. The name has a current market capitalization of $7.97 billion.

As for passive income investors, the company pays shareholders $0.08 per share annually in dividends, yielding 1.26%.

Intuit Inc. (INTU) was reiterated as ‘Buy’ with a $110 from $120 price target on Friday by Deutsche Bank (DB).  Currently there are 7 analysts that rate INTU a ‘Buy’, 1 analyst rates it a ‘Sell’, and 12 rate it a ‘Hold’.

INTU was up $0.13 at $85.90 in mid-day trade, moving within a 52-week range of $77.96 to $109.21. The name, valued at $23.82 billion, opened at $84.69.

On valuation measures, Intuit Inc. shares are currently priced at 67.00x this year’s forecasted earnings. Ticker has a t-12 price/sales ratio of 5.67. EPS for the same period registers at $1.28.

As for passive income investors, the firm pays stockholders $1.20 per share annually in dividends, yielding 1.34%.

Be the first to comment

Leave a Reply

Your email address will not be published.


*